Drugs / Amitriptylinoxide

Trials 2 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT02374567 Jan 2015 → Jun 2017 anxiety disorder, dementia, depressive disorder, schizophrenia +1 Hannover Medical School Terminated No outcome recorded
Phase 41 trial
Phase 4 NCT02237937 Sep 2011 → Dec 2014 major depressive disorder HolsboerMaschmeyer NeuroChemie GmbH Unknown No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Amitriptylinoxide ClinicalTrials.gov intervention name — accepted as the source's own label NCT02237937
Known as Ambivalon ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Known as Amitriptilinoxido ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Known as Amitriptyline oxide ClinicalTrials.gov intervention name — accepted as the source's own label NCT02374567
Known as Amitriptyline-n-oxide ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Known as Amitriptylinoxyde ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Known as Amitryptyline-n-oxide ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Known as Equilibrin ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Known as J9.621K ChEMBL registry synonym — accepted as the source's own label CHEMBL627
Modality Small molecule CHEMBL627